Mesoporous Silica Nanoparticles Research Articles

Surface Modification of Mesoporous Silica Nanoparticles for Application in Targeted Delivery Systems of Antitumour Drugs

The problem of tumour therapy has attracted the attention of many researchers for many decades. One of the promising strategies for the development of new dosage forms to improve oncology treatment efficacy and minimise side effects is the development of nanoparticle-based targeted transport systems for anticancer drugs. Among inorganic nanoparticles, mesoporous silica deserves special attention due to its outstanding surface properties and drug-loading capability. This review analyses the various factors affecting the cytotoxicity, cellular uptake, and biocompatibility of mesoporous silica nanoparticles (MSNs), constituting a key aspect in the development of safe and effective drug delivery systems. Special attention is paid to technological approaches to chemically modifying MSNs to alter their surface properties. The stimuli that regulate drug release from nanoparticles are also discussed, contributing to the effective control of the delivery process in the body. The findings emphasise the importance of modifying MSNs with different surface functional groups, bio-recognisable molecules, and polymers for their potential use in anticancer drug delivery systems.

Powerful Protein Nanoreservoirs Based on Stellate Mesoporous Silica Embedded in Composite Hydrogels: From Burst Release to Retention

AbstractIn the biomaterials field, one major issue with hydrogels (HGs) loaded with active therapeutics is the spontaneous leaking of the cargo occurring rapidly, usually over several hours. However, biological processes involved in regenerative medicine would require to have a sustained drug delivery lasting over weeks/months or be triggered only when a specific biochemical stimulus (enzymatic, cellular, or antimicrobial) is applied. In this work, this challenge is addressed by demonstrating that the spontaneous protein release from an agarose HG (used as model HG) can be partially or totally blocked by the incorporation of stellate mesoporous silica (STMS) nanoparticles (NPs, ≈150 ± 28 nm size, 15 nm pore) within the HG. It is shown here that the porous silica NPs act as sub‐micrometer size reservoirs ensuring precise level retention simply by playing on the amount of STMS embedded in the HG. Further, this effect is shown for various proteins demonstrating the versatility of this concept.

Antimicrobial properties and bonding durability of pH-responsive dentin adhesives with chlorhexidine-load mesoporous silica nanoparticles

In this study, we synthesized pH-sensitive CHX@SBA-PDA nanoparticles and characterized their structure. These nanoparticles were then incorporated into Single Bond 2 commercial dentin adhesive. Subsequently, timely and long-term antibacterial evaluation, cytotoxicity evaluation and bonding properties were conducted. The results demonstrated the successful synthesis of CHX@SBA-PDA nanoparticles. Moreover, CHX@SBA-PDA exhibited excellent pH sensitivity and maintained a high release rate of chlorhexidine (CHX) under cariogenic low pH conditions. At pH 5.0, the release rate could reach up to 71.1% after 24 h of incubation with CHX@SBA-PDA nanoparticles. Among the different adhesive formulations tested, the 2% wt adhesive displayed the strongest immediate and 30 days bacterial inhibition ability (p < 0.05). No significant difference was observed in immediate shear strength among the four groups (p > 0.05). After undergoing pH cycling, all functional adhesive groups exhibited higher shear strength compared to the control group (p < 0.05). Furthermore, there was no significant difference in cell proliferation activity between the experimental group and control group (p > 0.05). In conclusion, our functional dentin adhesive containing CHX@SBA-PDA nanoparticles demonstrated long-term antibacterial properties as well as improved bond strength characteristics, thus, offering a promising approach to enhance durability of bonded restorations.

The Antimicrobial Potency of Mesoporous Silica Nanoparticles Loaded with Melissa officinalis Extract

Melissa officinalis is an important medicinal plant that is used and studied intensively due to its numerous pharmacological effects. This plant has numerous active compounds with biomedical potential; some are volatile, while others are sensitive to heat or oxygen. Therefore, to increase stability and prolong biological activities, the natural extract can be loaded into various nanostructured systems. In this study, different loading systems were obtained from mesoporous silica, like Mobile Composition of Matter family (MCM) with a hexagonal (MCM-41) or cubic (MCM-48) pore structure, simple or functionalized with amino groups (using 3-aminopropyl) such as triethoxysilane (APTES). Thus, the four materials were characterized from morphological and structural points of view by scanning electron microscopy, a BET analysis with adsorption–desorption isotherms, Fourier-transform infrared spectroscopy (FTIR) and a thermogravimetric analysis coupled with differential scanning calorimetry. Natural extract from Melissa officinalis was concentrated and analyzed by High-Performance Liquid Chromatography to identify the polyphenolic compounds. The obtained materials were tested against Gram-negative bacteria and yeasts and against both reference strains and clinical strains belonging to Gram-positive bacteria that were previously isolated from intra-hospital infections. The highest antimicrobial efficiency was found against Gram-positive and fungal strains. Good activity was also recorded against methicillin-resistant S. aureus, the Melissa officinalis extract inhibiting the production of various virulence factors.

A Mesoporous Silica-loaded Multi-functional Hydrogel Enhanced Tendon Healing via Immunomodulatory and pro-regenerative Effects.

Tendon injuries are pervasive orthopedic injuries encountered by the general population. Nonetheless, recovery after severe injuries such as Achilles tendon injury is limited. Consequently, there is a pressing need to devise interventions, including biomaterials, that foster tendon healing. Regrettably, tissue engineering treatments have faced obstacles in crafting appropriate tissue scaffolds and efficacious nanomedical approaches. To surmount these hurdles, we have pioneered an innovative injectable hydrogel (CP@SiO2), comprising puerarin and chitosan through in situ self-assembly, while concurrently delivering mesoporous silica nanoparticles for tendon healing. In our research, we employed CP@SiO2 hydrogel for the treatment of Achilles tendon injuries, conducting extensive in vivo and in vitro experiments to evaluate its efficacy. Our results show that CP@SiO2 hydrogel significantly promotes the proliferation and differentiation of tendon-derived stem cells. BrdU assay results indicated a 12% increase in cell growth rate compared to gel treatment. Additionally, PCR results showed an increase in the expression of genes related to tendon differentiation and stemness maintenance. Moreover, the hydrogel effectively mitigated inflammation by promoting M2 polarization and inhibiting M1 polarization, thus alleviating macrophage-induced inflammation. The hydrogel also accelerated the recovery of injured tendon function; biomechanical assessments revealed that at 28 days post-operation, the load-to-failure ratio of tendons in the CP@SiO2 group was 53.28N, surpassing the 32.06N of the model group. Furthermore, we conducted a comprehensive in vivo evaluation using a tendon injury model, which included detailed histological analysis and behavioral observations. Our findings indicate that this multifaceted injectable CP@SiO2 hydrogel constitutes a suitable bioactive material for tendon repair and presents a promising new strategy for the clinical management of tendon injuries. This article is protected by copyright. All rights reserved.

In-Bath 3D Printing of Anisotropic Shape-Memory Cryogels Functionalized with Bone-Bioactive Nanoparticles.

Cryogels exhibit unique shape memory with full recovery and structural stability features after multiple injections. These constructs also possess enhanced cell permeability and nutrient diffusion when compared to typical bulk hydrogels. Volumetric processing of cryogels functionalized with nanosized units has potential to widen their biomedical applications, however this has remained challenging and relatively underexplored. In this study, we report a novel methodology that combines suspension 3D printing with directional freezing for the fabrication of nanocomposite cryogels with configurable anisotropy. When compared to conventional bulk or freeze-dried hydrogels, nanocomposite cryogel formulations exhibit excellent shape recovery (>95%) and higher pore connectivity. Suspension printing, assisted with a prechilled metal grid, was optimized to induce anisotropy. The addition of calcium- and phosphate-doped mesoporous silica nanoparticles into the cryogel matrix enhanced bioactivity toward orthopedic applications without hindering the printing process. Notably, the nanocomposite 3D printed cryogels exhibit injectable shape memory while also featuring a lamellar topography. The fabrication of these constructs was highly reproducible and exhibited potential for a cell-delivery injectable cryogel with no cytotoxicity to human-derived adipose stem cells. Hence, in this work, it was possible to combine a gravity defying 3D printed methodology with injectable and controlled anisotropic macroporous structures containing bioactive nanoparticles. This methodology ameliorates highly tunable injectable 3D printed anisotropic nanocomposite cryogels with a user-programmable degree of structural complexity.

Size Tuning of Mesoporous Silica Adjuvant for One-Shot Vaccination with Long-Term Anti-Tumor Effect

Despite recent clinical successes in cancer immunotherapy, it remains difficult to initiate a long-term anti-tumor effect. Therefore, repeated administrations of immune-activating agents are generally required in most cases. Herein, we propose an adjuvant particle size tuning strategy to initiate a long-term anti-tumor effect by one-shot vaccination. This strategy is based on the size-dependent immunostimulation mechanism of mesoporous silica particles. Hollow mesoporous silica (HMS) nanoparticles enhance the antigen uptake with dendritic cells around the immunization site in vivo. In contrast, hierarchically porous silica (HPS) microparticles prolong cancer antigen retention and release in vivo. The size tuning of the mesoporous silica adjuvant prepared by combining both nanoparticles and microparticles demonstrates the immunological properties of both components and has a long-term anti-tumor effect after one-shot vaccination. One-shot vaccination with HMS-HPS-ovalbumin (OVA)-Poly IC (PIC, a TLR3 agonist) increases CD4+ T cell, CD8+ T cell, and CD86+ cell populations in draining lymph nodes even 4 months after vaccination, as well as effector memory CD8+ T cell and tumor-specific tetramer+CD8+ T cell populations in splenocytes. The increases in the numbers of effector memory CD8+ T cells and tumor-specific tetramer+CD8+ T cells indicate that the one-shot vaccination with HMS-HPS-OVA-PIC achieved the longest survival time after a challenge with E.G7-OVA cells among all groups. The size tuning of the mesoporous silica adjuvant shows promise for one-shot vaccination that mimics multiple clinical vaccinations in future cancer immunoadjuvant development. This study may have important implications in the long-term vaccine design of one-shot vaccinations.

Bioinspired Hollow Mesoporous Silica Nanoparticles Coating on Titanium Alloy with Hierarchical Structure for Modulating Cellular Functions

Bioinspired Hollow Mesoporous Silica Nanoparticles Coating on Titanium Alloy with Hierarchical Structure for Modulating Cellular Functions

Targeted drug delivery to the lungs using mesoporous silica nanoparticles

Delivering drugs to tumour or defective cells effectively and efficiently while minimizing harmful side effects is one of the biggest issues facing the medical field. In order to address this issue, the pharmaceutical industry has developed a number of drug carriers that aid in getting the therapeutic medication or gene to the intended location. It has been discovered that mesoporous silica nanoparticles are biocompatible, chemically and thermally stable nanoparticles for this purpose the amount of research on MSNs has increased significantly in the last few years. Since 2001, when MCM-41 was first suggested as a drug carrier for a controlled delivery system, followed by SBA-15 and MCM-48. When changed, morphological features like pore size, pore volume, particle size, surface area, pH, and drug loading capacity have a significant impact on MSNs. Drug distribution to the intended place is elaborated by functionalizing MSNs with organic and inorganic groups. The most recent studies on MSN synthesis techniques and its uses in medical imaging, diagnostics, cellular uptake, target medication administration, cell tracing, and biosensing are also included in this review article.

Efficient self-healing coatings embedded with polydopamine modified BTA@DMSNs for corrosion protection

Dendritic mesoporous silica nanoparticles (DMSNs) were successfully prepared with a specific surface area of 608.8 m2/g and an average pore size of 24.2 nm, providing a strong support for the successful loading of benzotriazole (BTA). BTA@DMSNs were prepared using the vacuum impregnation method. A pH-responsive polydopamine (PDA) outer layer was self-polymerized on the surface to obtain BTA@DMSNs/PDA microcapsules. The pH-responsive BTA@DMSNs/PDA microcapsules were prepared with the high BTA content of 20.1 wt%. Mean diameter of microcapsules was 210 ± 25 nm. The release profiles under different pH conditions confirmed the pH-responsive behavior of BTA/DMSNs@PDA microcapsules. The coatings with 1 wt% BTA@DMSNs/PDA microcapsules exhibited optimal anti-corrosion and self-healing performance. The |Z|0.01Hz of EP/1 wt%/BTA/DMSNs@PDA remained the highest among all coatings even after being immersed in 3.5 wt% NaCl solution for 50 d through the EIS measurement. It only had a slight change from 3.8 × 1010 Ω·cm2 to 6.8 × 109 Ω·cm2, which was 80 times that of the EP for 50 d, indicating that the coatings had excellent long-term anti-corrosion effect and good shielding performance. Furthermore, the |Z|0.01Hz of the artificially cross-scratched coatings that were immersed for 30 d remained at 6.9 × 104 Ω·cm2, which was one order of magnitude higher than EP (6.3 × 103 Ω·cm2), and the surface of coatings remained intact, showing that the scratched coatings had outstanding self-healing performance.

An Injectable Magnesium-Based Cement Stimulated with NIR for Drug-Controlled Release and Osteogenic Potential.

Magnesium phosphate bone cement (MPC) has gained widespread usage in orthopedic implantation due to its fast-setting and high initial strength benefits. However, the simultaneous attainment of drug-controlled release and osteogenic potential in MPC remains a significant challenge. Herein, a strategy to create a smart injectable cement system using nanocontainers and chondroitin sulfate is proposed. It employs nanocontainers containing alendronate-loaded mesoporous silica nanoparticles, which are surface-modified with polypyrrole to control drug release in response to near-infrared (NIR) stimulation. The alendronate-incorporated cement (ACMPC) exhibits improved compressive strength (70.6 ± 5.9 MPa), prolonged setting time (913 s), and exceptional injectability (96.5% of injection rate and 242 s of injection time). It also shows the capability to prevent degradation, thus preserving mechanical properties. Under NIR irradiation, the cement shows good antibacterial properties due to the combined impact of hyperthermia, reactive oxygen species, and alendronate. Furthermore, the ACMPC (NIR) group displays good biocompatibility and osteogenesis capabilities, which also lead to an increase in alkaline phosphatase activity, extracellular matrix mineralization, and the upregulation of osteogenic genes. This research has significant implications for developing multifunctional biomaterials and clinical applications.

Immunomodulatory potential of rapamycin-loaded mesoporous silica nanoparticles: pore size-dependent drug loading, release, and in vitro cellular responses.

Rapamycin is a potent immunosuppressive drug that has been recently proposed for a wide range of applications beyond its current clinical use. For some of these proposed applications, encapsulation in nanoparticles is key to ensure therapeutic efficacy and safety. In this work, we evaluate the effect of pore size on mesoporous silica nanoparticles (MSN) as rapamycin nanocarriers. The successful preparation of MSN with 4 different pore sizes was confirmed by dynamic light scattering, zeta potential, transmission electron microscopy and N2 adsorption. In these materials, rapamycin loading was pore size-dependent, with smaller pore MSN exhibiting greater loading capacity. Release studies showed sustained drug release from all MSN types, with larger pore MSN presenting faster release kinetics. In vitro experiments using the murine dendritic cell (DC) line model DC2.4 showed that pore size influenced the biological performance of MSN. MSN with smaller pore sizes presented larger nanoparticle uptake by DC2.4 cells, but were also associated with slightly larger cytotoxicity. Further evaluation of DC2.4 cells incubated with rapamycin-loaded MSN also demonstrated a significant effect of MSN pore size on their immunological response. Notably, the combination of rapamycin-loaded MSN with an inflammatory stimulus (lipopolysaccharide, LPS) led to changes in the expression of DC activation markers (CD40 and CD83) and in the production of the proinflammatory cytokine TNF-α compared to LPS-treated DC without nanoparticles. Smaller-pored MSN induced more substantial reductions in CD40 expression while eliciting increased CD83 expression, indicating potential immunomodulatory effects. These findings highlight the critical role of MSN pore size in modulating rapamycin loading, release kinetics, cellular uptake, and subsequent immunomodulatory responses.

CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer

Pancreatic adenocarcinoma (PDAC) is highly resistant to conventional chemotherapeutic interventions, resulting in exceptionally low survival rates. The limited efficacy can in part be attributed to dose limitations and treatment cessation urged by toxicity of currently used chemotherapy. The advent of targeted delivery strategies has kindled hope for circumventing off-target toxicity. We have previously reported a PDAC-specific mesoporous silica nanoparticle (MSN) containing a protease linker responsive to ADAM9, a PDAC-enriched extracellularly deposited protease. Upon loading with paclitaxel these ADAM9-MSNs reduced side effects both in vitro and in vivo, however, disappointing antitumor efficacy was observed in vivo. Here, we propose that an efficient uptake of MSNs by tumor cells might underlie the lack of antitumor efficacy of MSNs functionalized with linker responsive to extracellular proteases. Harnessing this premise to improve antitumor efficacy, we performed an in silico analysis to identify PDAC-enriched intracellular proteases. We report the identification of BACE2, CAPN2 and DPP3 as PDAC enriched intracellular proteases, and report the synthesis of BACE2-, CAPN2- and DPP3-responsive MSNs. Extensive preclinical assessments revealed that paclitaxel-loaded CAPN2- and DPP3-MSNs exhibit high PDAC specificity in vitro as opposed to free paclitaxel. The administration of paclitaxel-loaded CAPN2- and DPP3-MSNs in vivo confirmed the reduction of leukopenia and induced no organ damage. Promisingly, in two mouse models CAPN2-MSNs reduced tumor growth at least as efficiently as free paclitaxel. Taken together, our results pose CAPN2-MSNs as a promising nanocarrier for the targeted delivery of chemotherapeutics in PDAC.

Improvement of Bone Homeostasis Imbalance in Osteoporotic Fractures by Mesoporous Silica Carrying miR-302b

miR-302b and DKK1 are two molecules related to the regulation of bone metabolism. Mesoporous silica is a potential drug carrier. This article aims to study the mechanism of mesoporous silica carrying miR-302b targeting DKK1 regulation to improve bone homeostasis imbalance in osteoporotic fractures. Mesoporous silica nanoparticles were synthesized and characterized. miR-302b was loaded into mesoporous silica to form composite nanoparticles. In vivo rat model experiments were performed to evaluate bone metabolism. X-ray examination and μCT scan were used to detect the bone content and trabecular bone status of rats. Alcian blue/hematoxylin/Orange G staining was used to observe changes in trabecular bone in the tibial metaphysis. Immunohistochemical staining showed the formation of trabecular bone in rats in each group and changes in the number of bone cells. Calcein double labeling experiment showed the bone mineralization speed of mice in each group. Pure and stable mesoporous silica nanoparticles were successfully synthesized and miR-302b was successfully loaded into the nanoparticles. The osteoporotic fracture rat model was successfully created. In vivo experimental results showed that after injecting composite nanoparticles into mice, bone density and bone strength were significantly increased and osteoporotic fractures were improved. Mesoporous silica carries miR-302b to target DKK1 regulation, which can improve bone homeostasis imbalance in osteoporotic fractures. Composite nanoparticles can inhibit the expression of DKK1, promote bone formation, and inhibit bone resorption, thereby improving bone density and bone strength.

Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport

Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport

Effective photothermal-photodynamic treatment of hepatocellular carcinoma based on polydopamine-coated mesoporous silica nanoparticles

The lack of tumor targeting ability and the ineffectiveness of single treatment modalities are two obstacles in the treatment of hepatocellular carcinoma (HCC). Herein, mesoporous silica nanoparticles (MSNs) with different sizes (MSN100 and MSN50) were synthesized and functionalized with polydopamine (PDA), hypericin B (HB), and arginine-glycine-aspartic acid (RGD) peptides for combined photothermal therapy (PTT) and photodynamic therapy (PDT) of HCC targeting αvβ3 integrin. MSN@PDA-RGD-HB were characterized by various techniques and showed selective drug release, high photothermal conversion efficiency, and reactive oxygen species (ROS) generation under laser irradiation. MSN100@PDA-RGD-HB exhibited higher cellular uptake and HCC toxicity than MSN50@PDA-RGD-HB in vitro, and specifically targeted HCC cells over normal cells. MSN100@PDA-RGD-HB demonstrated high biocompatibility in vivo, as confirmed by the hemolytic test and H&E staining. Importantly, MSN100@PDA-RGD-HB achieved a synergistic effect of PTT and PDT for HCC treatment in mice xenograft tumor model. Therefore, MSN100@PDA-RGD-HB has great potential for tumor therapy in the future.

Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics

Multimodal nanoparticles, utilizing quantum dots (QDs), mesoporous silica nanoparticles (MSNs), and gold nanoparticles (Au NPs), offer substantial potential as a smart and targeted drug delivery system for simultaneous cancer therapy and imaging. This method entails coating magnetic GZCIS/ZnS QDs with mesoporous silica, loading epirubicin into the pores, capping with Au NPs, PEGylation, and conjugating with epithelial cell adhesion molecule (EpCAM) aptamers to actively target colorectal cancer (CRC) cells. This study showcases the hybrid QD@MSN-EPI-Au-PEG-Apt nanocarriers (size ~65 nm) with comprehensive characterizations post-synthesis. In vitro studies demonstrate the selective cytotoxicity of these targeted nanocarriers towards HT-29 cells compared to CHO cells, leading to a significant reduction in HT-29 cell survival when combined with irradiation. Targeted delivery of nanocarriers in vivo is validated by enhanced anti-tumor effects with reduced side effects following chemo-radiotherapy, along with imaging in a CRC mouse model. This approach holds promise for improved CRC theranostics.

Self-responsive H2-releasing microneedle patch temporally adapts to the sequential microenvironment requirements for optimal diabetic wound healing

Oxidative stress regulation and synchronized promotion of angiogenesis are critical factors in the healing process of diabetic wounds. However, existing research often fails to fully consider the dynamic interplay between these two biological processes and their time-dependent roles in diabetic wound healing. This study innovatively introduces a novel hydrogen (H2)-releasing microneedle patch capable of precisely controlling the regulation of oxidative stress and the promotion of angiogenesis through a bidirectional responsive mechanism of microneedles and backing layers. Specifically, we employ ammonia borane (AB)-loaded mesoporous silica nanoparticles (MSN) as a source of H2, combined with polyvinyl pyrrolidone (PVP) to fabricate microneedles. This design effectively clears excessive reactive oxygen species (ROS) in deep tissues and promotes the M2 polarization of macrophages. Concurrently, we utilize cobalt-adsorbed graphene oxide (GO/Co2+) mixed with polyvinyl alcohol (PVA) to prepare backing layers, which not only release Co2+ upon the reduction of oxygen-containing functional groups in GO by H2 diffused from deep tissues to synergize with H2 for enhanced vascularization, but also endow the microneedle patch with near-infrared light-responsive antimicrobial properties, crucial for managing diabetic infected wounds. Through this innovative dual-action mechanism, our research significantly accelerates the healing process of infected wounds in a diabetic mouse model. Moreover, single-cell sequencing results further confirm the pivotal role of H2 in regulating oxidative stress, promoting macrophage M2 polarization, and stimulating angiogenesis. These results not only showcase the unique features of our microneedle patch but also offer new perspectives and therapeutic strategies for the treatment of diabetic wounds.

Fabrication of folic acid-modified bovine serum albumin cloaked dual-drug loaded hollow mesoporous silica nanoparticles for pH-responsive and targeted delivery of gastric cancer therapy

Combination therapy is a highly successful way to address the limitations of using a single treatment method and improve therapy's overall efficacy. In this study, we developed a unique hollow mesoporous silica nanoparticle (HMSN) coated with folic acid (FA)-modified bovine serum albumin (FA-BSA). This nanoparticle, referred to as HFB, was designed to target cancer cells and release dual therapeutic drugs, Indocyanine green (ICG) and Paclitaxel (PTX), in response to specific stimuli termed as HFB@IP. The BSA protein acts as a “gatekeeper” to prevent early drug releases and cargo leakage by detaching from BSA in reaction to GSH. The FA facilitates the targeted transport of the drug into cancer cells that express folate receptors (FR), enhancing the effectiveness of chemo-photodynamic treatment (PDT). The drug nanocarrier demonstrated in vitro pH/redox-triggered drug release from HFB@IP due to breaking the imine bonds between aldehyde-functionalized HMSN (CHO-HMSN) and FA-BSA with the disulfide bond inside BSA. In addition, various biological assessments, including cell uptake experiments, demonstrated that HFB@IP effectively targets SGC-7901 cells and induces apoptosis in vitro. Further, it exhibits remarkable efficiency in synergistically killing cancer cells through chemo-photodynamic therapy, as indicated by a combination index (CI) of 0.328. The results showed that combining HMSN with biodegradable stimuli-responsive BSA molecules could offer a promising approach for precise chemo-photodynamic therapy in treating gastric cancer, allowing for the controlled release of drugs as necessary.

Structural Elucidation and Development of Azelaic Acid loaded Mesoporous Silica Nanoparticles Infused Gel: Revolutionizing Nanodrug Delivery for Cosmetics and Pharmaceuticals

Structural Elucidation and Development of Azelaic Acid loaded Mesoporous Silica Nanoparticles Infused Gel: Revolutionizing Nanodrug Delivery for Cosmetics and Pharmaceuticals